Bored IIT graduate becomes a 'little shameless' on Instagram. He has life-changing experiences and conversations
Not every founder story needs to be about pitch decks and product pivots. Sometimes, it's just about being human. Harsh Pokharna , CEO of Bengaluru-based fintech startup OkCredit and an IIT Kanpur graduate, recently gave the internet something refreshingly real. During a 1.5-month break at home in Jaipur, Harsh found himself slipping into a familiar lull—parents were thrilled to have him home, but he was, by his own admission, kind of bored. So, he decided to shake things up in the most Gen-Z way possible: by posting an Instagram story inviting people in Jaipur to meet up.What followed was a low-key social experiment that turned into a deeply enriching experience. Harsh found himself going out almost daily—catching up with old friends, connecting with strangers from DMs, and indulging in conversations that ranged from the silly to the soul-stirring. Some chats were about food and therapy, others about breakups, startups, or dating apps. There were no rules, no agendas—just organic human connection in a world that's often too curated.While he didn't label the experience beyond 'wholesome,' the message was clear: sometimes all it takes to break out of a rut is a little shamelessness on Instagram and an open mind. His spontaneous 'Bumble for friends' in his hometown reminds us that meaningful interactions don't always come from planned networking or structured meetups—they can happen over coffee with a stranger or a walk with someone you haven't seen in years.In the photos, he can be seen hanging out and relaxing with different people. One image shows him playing badminton, while another captures a moment from his pickleball session. Other pictures feature him enjoying a car ride, dining at a restaurant, and sipping coffee, offering a glimpse into his laid-back, people-filled days in Jaipur.Harsh Pokharna completed his B.Tech in Mechanical Engineering from IIT Kanpur in 2014. After graduation, he gained valuable experience working with leading companies such as Intel Corporation, Flipkart, and Reliance Payment Solutions (JioMoney). In 2015, he ventured into entrepreneurship alongside his IIT Kanpur batchmates Gaurav Kumar and Aditya Prasad, co-founding ClanOut—a social discovery platform aimed at helping people connect and explore shared interests. Later, they co-founded the app OkCredit, where Pokharna is the CEO.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
13 minutes ago
- Economic Times
Can Granules India leverage its strong product pipeline to offset recent profit declines?
ET Intelligence Group: The stock of Granules India has shown a marginal recovery of 5% since August 11 despite lower absolute profits and margins reported by the pharma company in the June quarter. ADVERTISEMENT This has also reduced its one-month loss on the bourses to around 7%. Investor optimism hinges on the company's strong product pipeline and expected stabilisation in the recently acquired businesses. The company has guided for better growth rates in FY27 compared with the current fiscal year. In Europe, Granules has six products awaiting approval in coming quarters. The company continues to spend on large volume products in Central Nervous System (CNS) Attention Deficit Hyperactivity Disorder (ADHD) therapy and oncology. Granules acquired Senn Chemicals AG, a Switzerland-based peptides maker, at an enterprise value of ₹450 crore in early 2025. Granules targets an additional investment of ₹100 crore in this facility and ₹20-30 crore towards R&D lab in FY26. For FY27, capex will be for manufacturing expansion. Granules' one facility in Hyderabad will become operational by October and another commercial scale facility is targeted to complete by the end of FY27. The R&D facilities in India will have peptide synthesis as well as characterisation. It means the characterisation will happen in India even if drug development happens in Switzerland. The company believes it to become a cost-efficient source outside of China. ADVERTISEMENT The Gagillapur facility, one of the largest single-unit manufacturing sites for PFIs and finished dosages, is in the final stages of remediation with the US FDA with a fourth status report being submitted in July and no concerns being received so far. It has cleared inspections by German and Danish authorities, with Denmark granting an EU GMP certificate in July 2025. Unlock 500+ Stock Recos on App On a year-on-year basis, Granules' revenue from operations including Senn Chemicals (₹29.1 crore) grew 3% to ₹1,210.1 crore, driven by 7% and 12% rise in North America and Europe business. However, net profit dropped 16% to ₹112.6 crore in the June 2025 quarter. Ebitda margin dropped to 20.4% in June 2025 quarter from 22% a year ago, on account of higher manpower costs with consolidation of Senn Chemicals, which is expected to stabilise. ADVERTISEMENT Motilal Oswal Financial Services has reduced earnings estimates by 5% and 2% for FY26 and FY27 on account of increased timeline for approvals from Gagillapur facility, lower sales in some of the markets due to supply backlog. "While it is addressing the compliance aspect at Gagillapur site in a comprehensive manner, it is implementing efforts for adding differentiated products to its portfolio to improve growth prospects," it added. (You can now subscribe to our ETMarkets WhatsApp channel)
Time of India
28 minutes ago
- Time of India
Can Granules India leverage its strong product pipeline to offset recent profit declines?
ET Intelligence Group: The stock of Granules India has shown a marginal recovery of 5% since August 11 despite lower absolute profits and margins reported by the pharma company in the June quarter. This has also reduced its one-month loss on the bourses to around 7%. Investor optimism hinges on the company's strong product pipeline and expected stabilisation in the recently acquired businesses. The company has guided for better growth rates in FY27 compared with the current fiscal year. In Europe, Granules has six products awaiting approval in coming quarters. The company continues to spend on large volume products in Central Nervous System (CNS) Attention Deficit Hyperactivity Disorder (ADHD) therapy and oncology. Granules acquired Senn Chemicals AG , a Switzerland-based peptides maker, at an enterprise value of ₹450 crore in early 2025. Granules targets an additional investment of ₹100 crore in this facility and ₹20-30 crore towards R&D lab in FY26. For FY27, capex will be for manufacturing expansion . Agencies Granules' one facility in Hyderabad will become operational by October and another commercial scale facility is targeted to complete by the end of FY27. The R&D facilities in India will have peptide synthesis as well as characterisation. It means the characterisation will happen in India even if drug development happens in Switzerland. The company believes it to become a cost-efficient source outside of China. The Gagillapur facility, one of the largest single-unit manufacturing sites for PFIs and finished dosages, is in the final stages of remediation with the US FDA with a fourth status report being submitted in July and no concerns being received so far. It has cleared inspections by German and Danish authorities, with Denmark granting an EU GMP certificate in July 2025. On a year-on-year basis, Granules' revenue from operations including Senn Chemicals (₹29.1 crore) grew 3% to ₹1,210.1 crore, driven by 7% and 12% rise in North America and Europe business. However, net profit dropped 16% to ₹112.6 crore in the June 2025 quarter. Ebitda margin dropped to 20.4% in June 2025 quarter from 22% a year ago, on account of higher manpower costs with consolidation of Senn Chemicals, which is expected to stabilise. Motilal Oswal Financial Services has reduced earnings estimates by 5% and 2% for FY26 and FY27 on account of increased timeline for approvals from Gagillapur facility, lower sales in some of the markets due to supply backlog. "While it is addressing the compliance aspect at Gagillapur site in a comprehensive manner, it is implementing efforts for adding differentiated products to its portfolio to improve growth prospects," it added.
Economic Times
31 minutes ago
- Economic Times
Indian bonds see historic tightening of credit spreads amidst rating upgrade
Mumbai: Spreads between Indian bonds trading abroad and their benchmarks are at their narrowest ever, reflecting robust overseas interest in the world's fastest-expanding major economy that also saw a rating upgrade last week. ADVERTISEMENT Credit spreads on outstanding Indian bonds have shrunk further -and faster-after S&P upgraded New Delhi's sovereign rating for the first time since subprime mortgages fuelled the global financial crisis two decades ago. "Credit spreads, especially for investment-grade Indian paper, have come down and are at levels never seen before," said the head of debt capital markets at a UK based bank. "This is also partly because the supply of Indian paper has come down this year as issuers are wary of global uncertainties. But the fact is these are the best credit spreads enjoyed by Indian companies for a long time." Bankers said lower credit spreads on Indian bonds indicate wider acceptability and cheaper funding costs sovereign-backed Exim Bank had raised $1 billion through a 10-year bond sale in January this year. The bond was priced at 100 basis points above the 10-year US benchmark. The instrument is trading at 71 basis points above the 10-year US bond now. One basis point is 0.01 percentage point. Private-sector companies have also fared equally well. Reliance Industries' bond due in 2032 is currently trading at 63 basis points above the 10 year US treasury, the tightest since it was issued in 2022. The company had raised $1.5 billion and 120 basis points above the 10 year US treasury in 2022. Pratik Shah, head financial services, EY, said India's rating upgrade to BBB last week has further strengthened the attractiveness of Indian paper abroad. ADVERTISEMENT 'Best' Credit Quality Unlock 500+ Stock Recos on App "Credit quality of large Indian companies is probably at best ever. Their debt to equity is at near all-time best, so the chances of a credit event from India are very low," said Shah. "Then there are other factors like economic growth. Real GDP growth of India over the last four years has outpaced its peers." ADVERTISEMENT Bankers said weaker spreads indicate lower cost of borrowings for Indian companies through the overseas bond market. However, cheaper rupee funds and competitive overseas loan rates mean that companies would not want to spend time and money in finding investors to buy their bonds."A 10-year dollar loan for an investment-grade company out of India comes to about 5.40% currently, which is a good 30 to 40 basis points below the 5.7% 10-year bond rate for Indian companies currently," said the head of debt capital markets at a US-based bank. "Rupee funds are available at cheaper rates, considering the currency risk and hedging costs. So, despite the spreads being so narrow, it does not mean companies will rush to the bond market." ADVERTISEMENT With most Indian companies having limited overseas payments, going to the dollar bond market is also a big decision. (You can now subscribe to our ETMarkets WhatsApp channel)
